Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha

被引：4
|
作者：
Murphy, Philip T. [1 ]
McPherson, Suzanne [2 ]
Langabeer, Stephen E. [2 ]
机构：
[1] Beaumont Hosp, Dept Haematol, Dublin 9, Ireland
[2] St James Hosp, Dublin, Ireland
来源：
ANNALS OF HEMATOLOGY | 2011年 / 90卷 / 02期
关键词：
CHRONIC MYELOID-LEUKEMIA; MYELOPROLIFERATIVE DISORDERS; JAK2; V617F;
D O I：
10.1007/s00277-010-0993-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [1] Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha
    Philip T. Murphy
    Suzanne McPherson
    Stephen E. Langabeer
    Annals of Hematology, 2011, 90 : 233 - 234
  • [2] Therapeutic efficacy of recombinant interferon-alpha in polycythaemia vera
    Öztürk, A
    Günay, A
    Üskent, N
    ACTA HAEMATOLOGICA, 1998, 99 (02) : 89 - 91
  • [3] Interferon-Alpha (IFN) Therapy Discontinuation Is Feasible in Myeloproliferative Neoplasm (MPN) Patients with Complete Hematological Remission
    De Oliveira, Rafael Daltro
    Soret-Dulphy, Juliette
    Zhao, Lin-Pierre
    Marcault, Clemence
    Gauthier, Nicolas
    Verger, Emmanuelle
    Maslah, Nabih
    Parquet, Nathalie
    Raffoux, Emmanuel
    Vainchenker, William
    Chomienne, Christine
    Cassinat, Bruno
    Benajiba, Lina
    Kiladjian, Jean-Jacques
    BLOOD, 2020, 136
  • [4] Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera
    Stasi, R
    Brunetti, M
    Bussa, S
    Venditti, A
    DelPoeta, G
    Conforti, M
    Scimo, MT
    Cudillo, L
    Adorno, G
    Cecconi, M
    Amadori, S
    Pagano, A
    JOURNAL OF INTERNAL MEDICINE, 1997, 242 (02) : 143 - 147
  • [5] Interferon-alpha (IFN-a) given alone to CML patients with undetectable disease after imatinib (IM) is able to maintain their complete molecular remission after IM discontinuation
    Carella, A. M.
    BLOOD, 2007, 110 (11) : 210B - 210B
  • [6] Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera
    Foa, P
    Massaro, P
    Caldiera, S
    LaTargia, ML
    Iurlo, A
    Clerici, C
    Fornier, M
    Bertoni, F
    Maiolo, AT
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 60 (05) : 273 - 277
  • [7] Efficacy of recombinant interferon-alpha (rIFN-alpha) in polycythaemia vera: A study of 17 patients and an analysis of published data
    Taylor, PC
    Dolan, G
    Ng, JP
    Paul, B
    Collin, R
    Reilly, JT
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (01) : 55 - 59
  • [8] Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation
    A M Carella
    Leukemia, 2008, 22 : 1090 - 1091
  • [9] Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation
    Carella, A. M.
    LEUKEMIA, 2008, 22 (05) : 1090 - 1091
  • [10] Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha
    Verma, Dushyant
    Kantarjian, Hagop
    Jain, Nitin
    Cortes, Jorge
    LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1399 - 1402
12345